Johnson & Johnson Faces $400 Million in Tariff Costs as U.S.-China Trade Tensions Escalate

The company warns of potential additional costs from pharmaceutical tariffs under investigation by the Trump administration, while advocating for tax policy reforms to support U.S. manufacturing.